| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10129531 | American Heart Journal | 2018 | 26 Pages |
Abstract
A positive outcome of the OCTOBER trial may establish OCT as a routine tool for optimization of complex percutaneous coronary intervention, whereas a negative result would indicate that OCT remains a tool for ad hoc evaluation in selected cases.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Niels Ramsing Holm, Lene Nyhus Andreasen, Simon Walsh, Olli A. Kajander, Nils Witt, Christian Eek, Paul Knaapen, Lukasz Koltowski, Juan Luis Gutiérrez-Chico, Francesco Burzotta, Janusz Kockman, John Ormiston, Irene Santos-Pardo, Peep Laanmets,